Capricor Therapeutics (CAPR) shares fell Friday after the company announced it received a complete response letter from the FDA for its Biologics License Application for Deramiocel.

A recent enforcement action by the Federal Trade Commission (FTC) is particularly noteworthy because of the theory of ...

The $3.1 billion acquisition would combine Ferrero, which makes Tic Tacs and Nutella, with the producer of Frosted Flakes and ...

The FDA on Thursday said it published more than 200 decision letters, known as complete response letters, that it issued in response to applications for approval of drugs or biological products ...

Prospector Metals Corp. (TSXV: PPP) (OTCQB: PMCOF) (FSE: 1ET) ("Prospector" or the "Company") is pleased to announce it has ...

Warner Bros. Discovery's flagship streaming service will return to its original HBO Max name on Wednesday, ending an ...

Eba stands at the bow of research vessel Cheena, cruising the waters of the Canadian Gulf Islands where killer whales were ...